🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

HCA Healthcare, Inc. HCA SPXR3KPHARMA

Healthcare · Medical Care Facilities · United States
https://www.hcahealthcare.com
Company Profile ↓
$405.00
+4.43% 1Y
Mkt Cap$89.85B
P/E13.59
P/B-13.87
Div. Yield0.76%
52W High$543.23
52W Low$360.60
Book Value$-29.81
EPS (TTM)$29.81

Company Overview

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 12.3% per year over the last five years.

Reasonable Valuation

Trades at a P/E of 13.6, below the sector median of 25.2.

Healthy Margins

Operating margin of 15.2% supports profitability.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $75.60B (+7.1% YoY); net profit $6.78B.
  • Trailing 12 Months Year-on-year growth — revenue +8.7%, earnings +11.6%.
  • 5-Year Trend Long-term compounding — revenue CAGR 6.9%, profit CAGR 12.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:6.89%
1 Year:8.70%

Compounded Profit Growth

5 Years:12.34%
1 Year:11.60%

Stock Price Performance

1 Year:+4.43%
6 Months:-23.72%
3 Months:+9.05%
1 Month:-0.95%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 24% of range
$360.60 $543.23
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)46.44 · Neutral
Price Performance
1M-0.95%
3M+9.05%
6M-23.72%
1Y+4.43%
Valuation vs Sector

P/E of 13.59 is below the sector median of 25.17 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Profit CAGR of 12.3% over 5 years.
  • Generates positive free cash flow.

CONS

  • Trading 25.4% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
13.59
Industry PE
25.17
Forward P/E
12.59
PEG Ratio
1.32
Book Value
$-29.81
Price to Book
-13.87
P/S
1.18
EV/EBITDA
9.10
Dividend Yield
0.76%

Growth (CAGR)

Revenue 5Y
6.89%
Profit 5Y
12.34%
Revenue (YoY)
8.70%
Earnings (YoY)
11.60%

Profitability & Returns

ROCE
-
ROE
-112.56%
ROA
12.29%
Profit Margin
8.77%
Op Margin
15.16%
Gross Margin
42.58%
EPS (Latest Qtr)
$7.15
EPS (TTM)
$29.81

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
0.78
Current Ratio
0.99
Debt
$51.55B
Total Assets
$61.45B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
16.61%
Chg in Prom Hold
0.00%
FII / Inst Holding
78.93%
Chg in FII Hold
-0.02%

Financial Snapshot

Enterprise Value
$89.85B
Total Revenue (TTM)
$78.01B
EBITDA
$15.75B
Free Cash Flow
$3.74B
Operating Cash Flow
$11.12B
Shares Outstanding
221.84M
Gross Margin
42.58%
Payout Ratio
10.06%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 HCA HCA Healthcare, Inc. SPXR3KPHARMA 405.00 13.59 $89.85B 0.76% - -112.56% 6.89% 12.34%
2 LLY Eli Lilly and Company SPXR3KPHARMA 1,149.36 38.57 $1.02T 0.58% - 102.29% 7.20% 11.41%
3 JNJ Johnson & Johnson SPXR3KPHARMA 275.23 31.97 $663.28B 2.09% 14.88% 25.74% 2.43% 4.76%
4 ABBV AbbVie Inc. SPXR3KPHARMA 256.46 72.45 $453.19B 2.84% 10.47% -129.24% 1.75% -29.06%
5 MRK Merck & Co., Inc. SPXR3KPHARMA 150.33 120.26 $371.29B 2.65% - 34.70% 5.64% 10.01%
6 UNH UnitedHealth Group Incorporated SPXR3KPHARMA 397.14 25.54 $356.47B 2.33% 9.74% 14.15% 10.40% 5.43%
7 NVS Novartis AG PHARMA 159.99 24.20 $304.10B 3.03% 21.09% 30.35% 9.25% 26.22%
8 AZN AstraZeneca PLC NDXPHARMA 162.70 24.36 $252.33B 1.98% 15.97% 21.96% 9.82% 45.96%
9 AMGN Amgen Inc. NDXSPXR3KPHARMA 437.23 27.14 $235.98B 2.49% 13.95% 91.47% 5.51% 5.55%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ------------------------13.98B14.44B15.28B14.95B14.82B14.97B15.59B15.86B16.21B17.34B17.49B17.49B18.32B18.61B19.16B19.11B
Net Income 527.00M591.00M507.00M449.00M582.00M694.00M658.00M618.00M920.00M659.00M657.00M426.00M474.00M1.14B820.00M759.00M1.06B1.04B783.00M612.00M1.07B581.00M1.08B668.00M1.42B1.45B2.27B1.27B1.16B1.13B1.36B1.19B1.08B1.59B1.46B1.27B1.61B1.65B1.64B1.62B
Diluted EPS 1.191.361.181.051.401.691.651.592.391.741.751.151.303.182.312.153.012.972.251.763.091.693.161.954.144.367.004.143.903.914.854.293.915.935.534.886.456.836.967.15

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -------41.49B43.61B46.68B51.34B51.53B58.75B60.23B64.97B70.60B75.60B
Net Income 1.05B1.21B2.46B1.60B1.56B1.88B2.13B2.89B2.22B3.79B3.50B3.75B6.96B5.64B5.24B5.76B6.78B
Diluted EPS 2.442.764.973.493.374.164.997.305.9510.6610.0710.9321.1619.1518.9722.0028.33

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --23.85B26.90B28.07B28.59B30.98B32.74B33.76B36.59B39.21B45.06B47.49B50.74B52.44B56.21B59.51B60.72B
Total Equity -9.26B-7.98B11.93B-8.26B-9.66B-8.27B-7.89B-7.60B-7.30B-6.81B-4.95B-2.81B572.00M-933.00M-2.77B-1.77B-2.50B-6.03B
Cash & Equivalents 465.00M312.00M411.00M373.00M705.00M414.00M566.00M741.00M646.00M732.00M502.00M621.00M1.79B1.45B908.00M935.00M1.93B1.04B
Long Term Debt --27.63B25.64B27.50B27.59B29.09B30.25B31.16B32.86B32.03B33.58B30.80B34.34B37.71B37.17B38.33B41.60B
Total Liabilities ---33.91B36.42B35.76B37.48B38.79B39.39B41.59B42.12B45.62B------
Current Liabilities --4.27B5.55B6.17B5.70B5.48B5.52B5.83B6.16B7.57B7.76B8.70B9.58B9.90B12.65B15.18B16.35B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 2.75B3.08B3.93B4.17B3.68B4.45B-5.65B5.43B6.76B7.60B9.23B8.96B8.52B9.43B10.51B12.64B
Investing Cash Flow -1.03B-1.04B-3.00B-2.06B-2.35B-2.92B--3.24B-4.28B-3.90B-5.72B-3.39B-2.64B-3.39B-5.32B-4.93B-4.99B
Financing Cash Flow -1.86B-1.95B-976.00M-1.78B-1.62B-1.38B--2.51B-1.06B-3.08B-1.77B-4.68B-6.66B-5.66B-4.09B-4.58B-8.55B
Capital Expenditure -1.32B-1.32B-1.68B-1.86B-1.94B-2.18B-2.38B-2.76B-3.02B-3.57B-4.16B-2.83B-3.58B-4.39B-4.74B-4.88B-4.94B
Free Cash Flow 1.43B1.76B2.25B2.31B1.74B2.27B-2.89B2.41B3.19B3.44B6.40B5.38B4.13B4.69B5.64B7.69B
Net Change in Cash --------------523.00M20.00M999.00M-902.00M
Share Buybacks --1.50B-500.00M1.75B2.40B2.75B2.05B1.53B1.03B441.00M8.21B7.00B3.81B6.04B10.07B
Dividends Paid --------0487.00M550.00M153.00M624.00M653.00M661.00M690.00M679.00M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------------
Operating Margin % -----------------
Net Margin % -------7.0%5.1%8.1%6.8%7.3%11.8%9.4%8.1%8.2%9.0%
ROE % -13.2%10.1%-29.8%-16.6%-18.8%-23.8%-28.0%-39.6%-32.6%-76.5%-124.8%656.3%-745.6%-203.9%-295.5%-230.5%-112.6%
ROCE % -----------------

Shareholding Pattern

Insiders
16.61%
Institutions
78.93%
Public Float
94.65%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 6.01% 13.00M $5.43B
2 Vanguard Capital Management LLC 4.68% 10.14M $4.24B
3 Sanders Capital, LLC 4.08% 8.83M $3.69B
4 State Street Corporation 3.45% 7.47M $3.12B
5 Wellington Management Group, LLP 2.17% 4.71M $1.97B
6 Geode Capital Management, LLC 1.69% 3.67M $1.53B
7 First Eagle Investment Management, LLC 1.52% 3.30M $1.38B
8 Vanguard Portfolio Management LLC 1.25% 2.71M $1.13B
9 Morgan Stanley 1.19% 2.59M $1.08B
10 Goldman Sachs Group Inc 1.14% 2.46M $1.03B

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HCA

Google News Mon, 07 Sep 2026

185,804 Shares in HCA Healthcare, Inc. $HCA Bought by VIRGINIA RETIREMENT SYSTEMS ET Al - marketbeat.com

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxObnBoTmc2OWkyejdfRzlpWVhJOTJtckZKOG1DMEJ0LTJycXAyZVprWmdoa2pHM3pPcmkzQU9vZjk3MndUWmowUHVUcTVtb1RYUi1MQTFhWWcxUVhaRXdiWEYtR3dUXzRaVlRTS09oRG96aFRSeGdrc214aDJ1aHFuMHZWam8xNXcxZkVjZD…

Google News hu, 13 Aug 2026

Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQUkJxaUZTd3I4TVhPODB6MUxoWDBTZXMxNnM1ak9tRXZlQW9HS0tBRTdNYlY3b3JqeEpiWGRZVTZ0YlZoa1VvaVdGYXpKNHhJeUIxOEZVLWpRYk5LMzB0ZGdLbUZPTU1obzQ5OGdNeDZvc2QwU1AyQW5Malo2dEVTRlRVWUNBTkJtSkNnck…

Google News ue, 14 Jul 2026

HCA cuts 2026 earnings forecast on insurance coverage losses - Healthcare Dive

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOY2RtMUdESlQ1ZWJCVDZ0d3JjbENkWGVaS0Z5bkVLQ0h2aGFfOWdLRjRBZU84S1BvYjlHVnR3a3FnNGliUHZHWFBpYTgwNjBjTGZ1dUJhcHBSNW0zQk43aVB2aUZkVVllX3BCQ3RxSXlhRlk2bG9jX21KZloyNnd4bi1aUEo3R09uOF9YVk…

Google News hu, 03 Sep 2026

Is HCA Healthcare Stock Underperforming the Nasdaq? - Barchart.com

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNSS1IUlNIQlktZjF3aXE2eVVhMVFKSEhoVWE2T2tkbXpoaHRQOVZnMXVJTEhFOE1zVWpDcDBCTkp5a0Z1RmtrckUwZmJfY1lFTTVxU09TMWMxMnluNVVpUGxybE1vUHJYMW4yOHJXR3hHbDB3eDc2MU83Y0tpeGtoWHZ6QUpUR1VXcXVrej…

Google News ue, 01 Sep 2026

HCA Healthcare (HCA) Stock Still Looks Cheap Given Its Earnings Power - simplywall.st

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPaDlRUFM5cldhNzRERFVXU0tIYlFXb3BXdnRvN0syMXpKTnQtaHhYZkE4MFdkQUY5SFFqS2Zwc05rZ0JfOC03clM4NFllZGItM0YyanFIUGFETWZxVkx4REJqa1JlX2doWm5mNkh4M1BHVS1MWmRYU0ZYM1MzWm5saGI1QnRCSFJXQktzQW…

Google News Mon, 27 Jul 2026

HCA stock enters week after gaining value - Nashville Post

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxONVd1MnZOQnl0ZUdFRTFFdmZsNFRZTXExbmhLYlNlNjNNRzktSm5CcGdRRXR3d2dCbTFGME1IMVp5QTJNYUk5QVpoSWIxV3FURG5hVzZJblp2UlNiemozamY3TVFXTDhrNWdSV3duODBQRXpIb1dGRmtpR3FITkVtb3NsZm9CNWZVX3hMY3…

HCA — Frequently Asked Questions

What is the current share price of HCA Healthcare, Inc. (HCA)?

As of 2026-09-07 16:24 PDT, HCA Healthcare, Inc. (HCA) trades at $405.00 on NYSE. Its 52-week range is $360.60 to $543.23.

What is the market capitalisation of HCA?

HCA Healthcare, Inc. (HCA) has a market capitalisation of $89.85B on NYSE.

What is the P/E ratio of HCA?

HCA trades at a trailing price-to-earnings (P/E) ratio of 13.59. The industry average P/E is 25.17. Its price-to-book (P/B) ratio is -13.87.

Does HCA pay a dividend?

HCA Healthcare, Inc. (HCA) currently offers a dividend yield of 0.76%.

What is the return on equity (ROE) of HCA?

HCA has a return on equity (ROE) of -112.56%.

Is HCA a good stock to buy?

This page provides a data-driven analysis of HCA Healthcare, Inc. (HCA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space